Çocuk Dergisi

GÖNDERBİLGİ
EnglishTürkçe

Derleme


DOI :10.5222/j.child.2016.074   IUP :10.5222/j.child.2016.074    Tam Metin (PDF)

Çocuk Solid Organ Nakli Enfeksiyonları

Selda Hançerli Törün, Manolya Kara, Nuran Salman, Ayper Somer

Solid organ nakli (SON) son dönem böbrek, karaciğer, kalp ve akciğer hastalıklarında dünyada 30 yılı aşkın süredir başarıyla uygulanmaktadır. Enfeksiyonlar SON yapılan çocuklarda önemli bir morbidite ve mortalite nedeni olmaktadır. Bu derlemede, SON yapılan çocuklarda sık görülen enfeksiyon sendromlarının ve etken patojenlerin tanımlanması, enfeksiyonun zamanlaması ve risk faktörlerinin saptanması ve koruyucu önlemerin rehberler eşliğinde ele alınması amaçlanmıştır.

Anahtar Kelimeler: Solid organ nakli, pediatri, enfeksiyon
DOI :10.5222/j.child.2016.074   IUP :10.5222/j.child.2016.074    Tam Metin (PDF)

Infections Related to Solid Organ Transplantations in Children

Selda Hançerli Törün, Manolya Kara, Nuran Salman, Ayper Somer

The use of solid organ transplantation (SOT) has been successfully performed for end-stage disease of the kidneys, liver, heart and lungs for nearly 30 years. Infections are important causes of morbidity and mortality in children undergoing solid organ transplantation. This review aimed to identify risk factors for and timing of infections, to describe the common infectious syndromes and pathogens seen in children undergoing solid organ transplantation, and to review preventive strategies according to the guidelines.

Anahtar Kelimeler: Solid organ transplantation, pediatrics, infection

PDF Görünüm

Referanslar

  • 1. Green M. Introduction: Infections in Solid Organ Transplantation. Am J Transplantation 2013; 13:3-8. google scholar
  • 2. Green M, Michaels M. Infections in pediatric solid organ transplant recipients. J Pediatric Infectious Diseases Society 2012;1(2):144-51. https://doi.org/10.1093/jpids/pir001 google scholar
  • 3. Keough WL, Michaels MG. Infectious complications in pediatric solid organ transplantation. Pediatr Clin N Am 2003;50:1451-69. https://doi.org/10.1016/S0031-3955(03)00126-3 google scholar
  • 4. Koo S, Marty FM, Baden LR. Infectious complications associated with immunomodulating biologic agents. Inf Dis Clin N Am 2010;24:285-306. https://doi.org/10.1016/j.idc.2010.01.006 google scholar
  • 5. Martin-Pena A, Cordero E, Fijo J, et al. Prospective study of infectious complications in a cohort of pediatric renal transplant recipients. Pediatr Transplant 2009; 13:457-63. https://doi.org/10.1111/j.1399-3046.2008.01019.x google scholar
  • 6. Green M, Covington S, Taranto S, et al. Donorderived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation 2015;99(2):282. https://doi.org/10.1097/TP.0000000000000584 google scholar
  • 7. Humar A, Snydman D and the AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009;9(Suppl 4):S78-86. https://doi.org/10.1111/j.1600-6143.2009.02897.x google scholar
  • 8. Wagener MM, Yu VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors and outcomes. Am J Infect Control 1992;20:239-4. https://doi.org/10.1016/S0196-6553(05)80197-X google scholar
  • 9. Gorensek MJ, Carey WD, Washington JA, et al. Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med 1993; 60:139-44. https://doi.org/10.3949/ccjm.60.2.139 google scholar
  • 10. Fox BC, Sollinger HW, Belzer FO, et al. A prospective, randomized,double-blind study of trimethoprimsulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption, trimethoprim-sulfamethoxazole effects on the microflora, and the costbenefit of prophylaxis. Am J Med 1990;89:255-74. https://doi.org/10.1016/0002-9343(90)90337-D google scholar
  • 11. Playford EG, Webster Sorell TC, et al. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database Syst Rev 2004;(3):CD004291 https://doi.org/10.1002/14651858.CD004291.pub2 google scholar
  • 12. Pappas PG, Kauffman CA, Andes D, et al. Infectious Diseases Society of America Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48(5):503. https://doi.org/10.1086/596757 google scholar
  • 13. Kontoyiannis D, Marr K, Park B, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010;50:10911100. https://doi.org/10.1086/651263 google scholar
  • 14. Vazquez JA, Marisa H et al. Invasive fungal infections in transplant recipients. Ther Adv Infect Dis 2013;1(3):8510. https://doi.org/10.1177/2049936113491936 google scholar
  • 15. Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis 2001;33(8):1397. https://doi.org/10.1086/323129 google scholar
  • 16. Schwartza BS, Mawhorterb SD and the AST Infectious Diseases Community of Practice. Parasitic Infections in Solid Organ Transplantation. Am J Çocuk Dergisi 16(3-4):74-85, 2016 84 Transplantation 2013;13:280-303. https://doi.org/10.1111/ajt.12120 google scholar
  • 17. Young J-AWD. Typical and atypical Mycobacterium infections after hematopoietic stem cell or solid organ transplantation. In: Bowden RA, Snydman DR, eds. Transplant infections. Philadelphia, PA: Wolters Kluwer/Lippincott Williams&Wilkins, 2010, pp. 195– 203. google scholar
  • 18. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: Incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009;48:1657-65. https://doi.org/10.1086/599035 google scholar
  • 19. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solid-organ transplant recipients: Consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009;48:1276-84. https://doi.org/10.1086/597590 google scholar
  • 20. Subramaniana AK, Morrisb MI and the AST Infectious diseases community of practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplantation 2013;13:68-76. google scholar
  • 21. Fiore AE, Fry A, Shay D, Gubareva L, et al. Centers for Disease Control and Prevention (CDC) SOMMWR Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). Recomm Rep 2011;60(1):1. google scholar
  • 22. Karen C. Lara A. David B. Cytomegalovirus infection in pediatric solid organ transplant recipients: a focus on prevention Curr. Infect Dis Rep 2016;18:5. google scholar
  • 23. Hodson EM, Jones CA, Webster AC, et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005;365(9477):2105. https://doi.org/10.1016/S0140-6736(05)66553-1 google scholar
  • 24. Munoz-Price LS, Slifkin M, Ruthazer R, et al. The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 2004;39:1293-9. https://doi.org/10.1086/425002 google scholar
  • 25. George MJ, Snydman DR, Werner BG, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, Med Immune, Inc. Gaithersburg, Maryland. Am J Med 1997;103:106-13. https://doi.org/10.1016/S0002-9343(97)80021-6 google scholar
  • 26. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999;68: 1305-11. https://doi.org/10.1097/00007890-199911150-00015 google scholar
  • 27. Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial. Am J Transplant 2008;8:975-83. https://doi.org/10.1111/j.1600-6143.2007.02133.x google scholar
  • 28. Danziger-Isakov L, Bucavalas J. Current prevention strategies against cytomegalovirus in the studies in pediatric liver transplantation (SPLIT) centers. Am J Transplant 2014;14(8):1908-11. https://doi.org/10.1111/ajt.12755 google scholar
  • 29. Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013;96(4):333-60. https://doi.org/10.1097/TP.0b013e31829df29d google scholar
  • 30. Razonablea RR, Humarb A and the AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. American Journal of Transplantation 2013;13:93-106. google scholar
  • 31. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010; 23: 689–712 https://doi.org/10.1128/CMR.00009-10 google scholar
  • 32. Allen UD. The ABC of Epstein-Barr virus infectionsHot topics in infection and immunity in children. Adv Exp Med Biol 2005;568:25-39. https://doi.org/10.1007/0-387-25342-4_3 google scholar
  • 33. Caillard S, Lamy FX, Quelen C, et al. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: Report of the French registry and analysis of subgroups of lymphomas. Am J Transplant 2012;12:682-93. https://doi.org/10.1111/j.1600-6143.2011.03896.x google scholar
  • 34. Allena UD, Preiksaitisd JK and the AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplantation 2013;13:107-20. google scholar
  • 35. Swerdlow SH, Webber SA, Ferry JA, et al. A posttransplant lymphoproliferative disorders. WHO classification of tumors of haematopoietic and lymphoid tissues, 4th Ed. Lyons: International Agency for Research on Cancer/WHO, 2008 google scholar
  • 36. Opelz G, Daniel V, Naujokat C, et al. Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on posttransplant non-Hogkin lymphoma: A multicentre retrospective analysis. Lancet Oncol S. Hançerli Törün ve ark., Çocuk Solid Organ Nakli Enfeksiyonları 85 2007; 8:212-8. https://doi.org/10.1016/S1470-2045(07)70040-2 google scholar
  • 37. Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial. Am J Transplant 2008;8:1016-24. https://doi.org/10.1111/j.1600-6143.2008.02183.x google scholar
  • 38. Martin SI, Dodson B, Wheeler C, et al. Monitoring infection with Epstein-Barr Virus among seromismatch adult renal transplant recipients. Am J Transplant 2011;11:1058-63. https://doi.org/10.1111/j.1600-6143.2011.03478.x google scholar
  • 39. Parker A, Bowles K, Bradley A, et al. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients-BCSH and BTS Guidelines. Br J Haematol 2010;149:675-92. https://doi.org/10.1111/j.1365-2141.2010.08161.x google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Hançerli Törün, S., Kara, M., Salman, N., & Somer, A. (2016). Çocuk Solid Organ Nakli Enfeksiyonları. Çocuk Dergisi, 16(2), 74-85. https://doi.org/10.5222/j.child.2016.074


AMA

Hançerli Törün S, Kara M, Salman N, Somer A. Çocuk Solid Organ Nakli Enfeksiyonları. Çocuk Dergisi. 2016;16(2):74-85. https://doi.org/10.5222/j.child.2016.074


ABNT

Hançerli Törün, S.; Kara, M.; Salman, N.; Somer, A. Çocuk Solid Organ Nakli Enfeksiyonları. Çocuk Dergisi, [Publisher Location], v. 16, n. 2, p. 74-85, 2016.


Chicago: Author-Date Style

Hançerli Törün, Selda, and Manolya Kara and Nuran Salman and Ayper Somer. 2016. “Çocuk Solid Organ Nakli Enfeksiyonları.” Çocuk Dergisi 16, no. 2: 74-85. https://doi.org/10.5222/j.child.2016.074


Chicago: Humanities Style

Hançerli Törün, Selda, and Manolya Kara and Nuran Salman and Ayper Somer. “Çocuk Solid Organ Nakli Enfeksiyonları.” Çocuk Dergisi 16, no. 2 (Jun. 2025): 74-85. https://doi.org/10.5222/j.child.2016.074


Harvard: Australian Style

Hançerli Törün, S & Kara, M & Salman, N & Somer, A 2016, 'Çocuk Solid Organ Nakli Enfeksiyonları', Çocuk Dergisi, vol. 16, no. 2, pp. 74-85, viewed 26 Jun. 2025, https://doi.org/10.5222/j.child.2016.074


Harvard: Author-Date Style

Hançerli Törün, S. and Kara, M. and Salman, N. and Somer, A. (2016) ‘Çocuk Solid Organ Nakli Enfeksiyonları’, Çocuk Dergisi, 16(2), pp. 74-85. https://doi.org/10.5222/j.child.2016.074 (26 Jun. 2025).


MLA

Hançerli Törün, Selda, and Manolya Kara and Nuran Salman and Ayper Somer. “Çocuk Solid Organ Nakli Enfeksiyonları.” Çocuk Dergisi, vol. 16, no. 2, 2016, pp. 74-85. [Database Container], https://doi.org/10.5222/j.child.2016.074


Vancouver

Hançerli Törün S, Kara M, Salman N, Somer A. Çocuk Solid Organ Nakli Enfeksiyonları. Çocuk Dergisi [Internet]. 26 Jun. 2025 [cited 26 Jun. 2025];16(2):74-85. Available from: https://doi.org/10.5222/j.child.2016.074 doi: 10.5222/j.child.2016.074


ISNAD

Hançerli Törün, Selda - Kara, Manolya - Salman, Nuran - Somer, Ayper. “Çocuk Solid Organ Nakli Enfeksiyonları”. Çocuk Dergisi 16/2 (Jun. 2025): 74-85. https://doi.org/10.5222/j.child.2016.074



ZAMAN ÇİZELGESİ


Gönderim05.06.2017
Kabul24.08.2017

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ



İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.